86 related articles for article (PubMed ID: 19740626)
1. Pharmacokinetics of topiramate during pregnancy.
Ohman I; Sabers A; de Flon P; Luef G; Tomson T
Epilepsy Res; 2009 Dec; 87(2-3):124-9. PubMed ID: 19740626
[TBL] [Abstract][Full Text] [Related]
2. Serum concentration/dose ratio of topiramate during pregnancy.
Westin AA; Nakken KO; Johannessen SI; Reimers A; Lillestølen KM; Brodtkorb E
Epilepsia; 2009 Mar; 50(3):480-5. PubMed ID: 19178558
[TBL] [Abstract][Full Text] [Related]
3. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations.
Ohman I; Vitols S; Luef G; Söderfeldt B; Tomson T
Epilepsia; 2002 Oct; 43(10):1157-60. PubMed ID: 12366729
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
Ohman I; Beck O; Vitols S; Tomson T
Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing serum topiramate concentrations in routine therapeutic drug monitoring in Korean adult patients with epilepsy.
Huh HJ; Joo EY; Hong SB; Ahn JH; Seo DW; Lee SY
Ther Drug Monit; 2013 Apr; 35(2):177-82. PubMed ID: 23503443
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
[TBL] [Abstract][Full Text] [Related]
8. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.
Shank RP; Doose DR; Streeter AJ; Bialer M
Epilepsy Res; 2005 Feb; 63(2-3):103-12. PubMed ID: 15715969
[TBL] [Abstract][Full Text] [Related]
9. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry.
Matar KM
Clin Chim Acta; 2010 May; 411(9-10):729-34. PubMed ID: 20138857
[TBL] [Abstract][Full Text] [Related]
12. Topiramate pharmacokinetics in infants.
Glauser TA; Miles MV; Tang P; Clark P; McGee K; Doose DR
Epilepsia; 1999 Jun; 40(6):788-91. PubMed ID: 10368080
[TBL] [Abstract][Full Text] [Related]
13. Effect of CYP Inducers/Inhibitors on Topiramate Concentration: Clinical Value of Therapeutic Drug Monitoring.
Yamamoto Y; Takahashi Y; Imai K; Kagawa Y; Inoue Y
Ther Drug Monit; 2017 Feb; 39(1):55-61. PubMed ID: 27941476
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
16. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
17. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method.
la Marca G; Malvagia S; Filippi L; Fiorini P; Innocenti M; Luceri F; Pieraccini G; Moneti G; Francese S; Dani FR; Guerrini R
J Pharm Biomed Anal; 2008 Dec; 48(5):1392-6. PubMed ID: 18980824
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
20. Effect of pregnancy on topiramate pharmacokinetics in rabbits.
Matar KM; Marafie NA
Xenobiotica; 2011 May; 41(5):416-21. PubMed ID: 21271806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]